MRG006A

· Lepu Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MRG006A, covering 2026-01-22 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II) [Phase 1, Phase 2]